METHODS OF DETECTING PROSTATE CANCER

METHODS FOR SEQUENCING SAMPLES

StarTrace: A Multiplex Drug Testing Platform for Personalized Medicine

Biomarkers for Long COVID

COMPARATIVE ASSESSMENT OF NANOPARTICLE DELIVERY VEHICLES

Gene Transcripts as Signatures for Tead-Active Cancer

METHODS, COMPOSITIONS, KITS AND USES THEREOF TARGETING AND/OR TREATING VRK2 TO ENHANCE EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITOR(S)

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

BIOMARKER FOR DIAGNOSIS OF GASTRIC CANCER

GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF CANCER

BIOMARKER PANEL FOR DIAGNOSING CMS4 SUBTYPE OF COLORECTAL CANCER AND DIAGNOSTIC METHOD USING THE SAME

ADAM32 GENE IN THE DIAGNOSIS AND TREATMENT OF LUNG ADENOCARCINOMA

DIGITALIZED HUMAN ORGANOIDS AND METHODS OF USING SAME

METHODS FOR AFFECTING TISSUE-RESIDENT T CELLS

NOVEL BIOMARKERS FOR DIAGNOSING PANCREATIC CANCER

METHODS FOR DETERMINING MITOCHONDRIAL DNA DAMAGE

MULTI-TIERED TESTING FOR TRACKING DISEASE HETEROGENEITY

ASSAY AND METHODS FOR DRUG DISCOVERY

Methods for Manipulating Phagocytosis Mediated by CD47

A METHOD OF DETERMINING THE DOSE OF PSYCHEDELICS

PARTIAL-EMT SIGNATURE FOR PREDICTION OF HIGH-RISK HISTOPATHOLOGIC FEATURES AND CANCER OUTCOMES ACROSS DEMOGRAPHIC POPULATIONS

CIRCULATING MUTANT DNA TO ASSESS TUMOR DYNAMICS

METHOD OF IN SITU GENE SEQUENCING

DNA-METHYLATION DETECTION IN ANIMAL-DERIVED PRODUCTS

METHOD FOR CONSTRUCTING HOTSPOT-DERIVED PEPTIDE-NUCLEIC ACID HYBRID MOLECULES ON BASIS OF IN VITRO SELECTION

METHODS AND SYSTEMS FOR DEVELOPING PERSONALIZED VACCINE BY IDENTIFICATION AND PRIORITIZATION OF MUTATION-DERIVED NEOANTIGENS

ALGORITHM AND AN IN VITRO METHOD BASED ON RNA EDITING TO SELECT PARTICULAR EFFECT INDUCED BY ACTIVE COMPOUNDS

TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT

Methods and Compositions for Inhibiting Viral Infection

COMPOSITIONS AND METHODS FOR THERAPEUTICS PRESCREENING

PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER COMPRISING NUPR1 ISOFORM A INHIBITOR

METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY

NOVEL ORGANISM BREEDING TECHNIQUE

CARPOOL: A High Throughput in Vitro and in Vivo Screening Platform

MULTI-TIERED TESTING FOR TRACKING CANCER HETEROGENEITY

KIF5B-RET FUSION MOLECULES AND USES THEREOF

METHODS AND COMPOSITIONS FOR TARGETED DELIVERY OF INTRACELLULAR BIOLOGICS

METHOD FOR DETERMINING THE ACTIVITY OF A DRUG OR DRUG CANDIDATE UNDER CONDITIONS OF MICROGRAVITY

METHODS FOR SEQUENCING SAMPLES

NLRP3 Variants & Library Screen for NLRP3 Inhibitors with the Same

METHOD FOR HORMONE OR DRUG SCREENING IN A TISSUE SAMPLE

ANTI-CORONAVIRUS EFFECT AND APPLICATION OF P14K INHIBITOR

BCR-ABL VARIANTS

UTERINE CANCER TREATMENTS

COMPOSITION AND METHOD FOR EVALUATING RESPONSIVENESS OF EDARAVONE

HIGH ATP-AFFINITY PROTEIN AS THERAPEUTIC TARGET FOR INTRACTABLE CANCER MOLECULAR SUBTYPES AND INHIBITOR THEREOF

ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

GENE EXPRESSION PROFILES ASSOCIATED WITH CHRONIC ALLOGRAFT NEPHROPATHY

EPIGENOME BIOMARKERS FOR IDENTIFYING ALZHEIMER'S DISEASE

METHODS OF DETECTING DISEASES OR CONDITIONS USING PHAGOCYTIC CELLS

IN VITRO OR EX VIVO METHODS FOR SCREENING A QUINOLINE DERIVATIVE

Antisense Nucleic Acids

COMPOSITIONS AND METHODS FOR BASE EDITING KINASE GENES

NOVEL BIOMARKER FOR DETECTION OF CANCER METASTASIS

COMPOSITIONS AND METHODS FOR IMMUNE REPERTOIRE SEQUENCING

NON-INVASIVE DIAGNOSTIC OF NON-ALCOHOLIC STEATOHEPATITIS

EXOSOME-DERIVED MICRORNA BIOMARKER FOR DIAGNOSIS OF PREMATURE OVARIAN INSUFFICIENCY (POI) AND USE THEREOF

METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT PROTEIN DELIVERY, SCREENING, AND DETECTION

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF METABOLIC DISORDERS

GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA

APPLICATION OF HYDRAZIDE COMPOUND IN TUMOR TREATMENT

PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMC) PHENOTYPES AS BIOMARKERS FOR PATIENTS WITH ALZHEIMER'S DISEASE AND/OR MILD COGNITIVE IMPAIRMENT (MCI)

METHODS OF USING miR-3075-5P TO IMPROVE INSULIN SENSITIVITY AND COMPOSITIONS THEREFOR

Selective Reduction of Allelic Variants

METHOD OF SCREENING FOR AGENTS FOR DIFFERENTIATING STEM CELLS

NOVEL BIOMARKER FOR DIAGNOSING AND PREDICTING METASTASIS OR PROGNOSIS OF VARIOUS CANCERS, AND USE

SYNTHETIC BARCODING OF CELL LINE BACKGROUND GENETICS

NOVEL THERAPEUTIC AGENT FOR SEPTICEMIA, AND A METHOD FOR SCREENING FOR SAME

KIT FOR DIAGNOSIS OF CANCER AND USE THEREOF

METHODS AND COMPOSITIONS COMPRISING FUNCTIONAL GENOMICS OF HIBERNATING MAMMALS

METHODS FOR INHIBITING MUSCLE ATROPHY

Use Of LncRNA DCRT As Drug And Its Drug For Treating Cardiovascular Diseases, Screening Method, And Preparation Method Thereof

SPATIOTEMPORALLY RESOLVED TRANSCRIPTOMICS AT SUBCELLULAR RESOLUTION

TREATMENT AND DIAGNOSIS OF MELANOMA

DIAGNOSING INFLAMMATORY BOWEL DISEASES

FOCAL ADHESION KINASE SPLICING ISOMER AND APPLICATION THEREOF

MARKERS TO PREDICT MACROCYCLIC LACTONE DRUG RESISTANCE IN DIROFILARIA IMMITIS, THE CAUSATIVE AGENT OF HEARTWORM DISEASE

METHYLATION MARKERS FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER CANCERS

CELL-OF-ORIGIN TARGETED DRUG REPURPOSING FOR TRIPLE-NEGATIVE AND INFLAMMATORY BREAST CARCINOMA WITH HDAC AND HSP90 INHIBITORS COMBINED WITH NICLOSAMIDE

METHODS AND COMPOSITIONS RELATED TO CELL-CYCLE RNA's

Non-Small Cell Lung Cancer Diagnosis and Treatment

BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS

METHODS AND SYSTEMS OF PROCESSING COMPLEX DATA SETS USING ARTIFICIAL INTELLIGENCE AND DECONVOLUTION

COMPOSITION FOR DIFFERENTIAL DIAGNOSIS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMOR

METHOD FOR SUPPRESSING CANCER METASTASIS THROUGH ALTERATION OF ADHESION DEPENDENCE OF CANCER CELLS

Methods for sequencing samples

Methods for sequencing samples

HIGH RESOLUTION MULTIPLEX METHOD FOR DETECTING AT LEAST TWO TARGETS WITH A DISTANCE OF BEYOND THE DIFFRACTION LIMIT IN A SAMPLE

COMPOSITIONS AND METHODS FOR IN VIVO SCREENING OF THERAPEUTICS USING SINGLE NUCLEUS SEQUENCING

SYSTEM AND METHOD FOR DISCOVERING VALIDATING AND PERSONALIZING TRANSPOSABLE ELEMENT CANCER VACCINES

NOVEL DIAGNOSTIC AND METHOD OF SCREENING THERAPEUTICS FOR FIBROTIC CONDITIONS

METHOD FOR IDENTIFYING INTERVENTIONS THAT CONTROL THE TRANSLATIONAL ACTIVITY OF RIBOSOMAL PROTEINS IN DIFFERENTIAL MRNA EXPRESSION

METHODS OF TREATING LIPEDEMA INCLUDING AKR1C2 AS A THERAPEUTIC TARGET

TARGETING CHROMOSOMAL INSTABILITY AND DOWNSTREAM CYTOSOLIC DNA SIGNALING FOR CANCER TREATMENT

CHEMICAL SENSOR USING STRAND EXCHANGE REACTION

Synthetic Fluorescent Protein Biosensors and Use Thereof in Drug Screening Methods

Methods for sequencing samples

MEK1 Mutation Conferring Resistance to RAF and MEK Inhibitors

DIAGNOSTIC METHODS

MIR-7-5P MIMIC FOR INHIBITING MIGRATION AND INVASION OF BREAST CANCER, SCREENING METHOD AND APPLICATION THEREOF

METHOD FOR IDENTIFYING SUBSTANCE CAPABLE OF AFFECTING AGING

Anti-SARS-CoV-2-Spike Glycoprotein Antibodies and Antigen-Binding Fragments

METHODS OF DIAGNOSING ALZHEIMER'S DISEASE AND RISK OF PROGRESSION TO ALZHEIMER'S DISEASE

CIRCULATING MUTANT DNA TO ASSESS TUMOR DYNAMICS

METHODS FOR SELECTING MEDICATIONS

MODULATION OF GENE EXPRESSION AND SCREENING FOR DEREGULATED PROTEIN EXPRESSION

Methods for sequencing samples

ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

METHODS FOR IDENTIFYING DRIVERS OF IMMUNE RESPONSES USING MOLECULAR EXPRESSION SIGNATURES OF IMMUNOMODULATING AGENTS

RNA INTERACTOME CAPTURING PROTOCOL AND ANTIVIRAL COMPOSITION DISCOVERED USING SAME

Method to Regulate ALOX12-AS1 IncRNA-Mediated Alteration of ALOX12 Protein and to Screen for Novel Drugs to Alter ALOX12 Protein Level

METHOD OF TREATING OR PREVENTING NEURODEGENERATION

Gene expression profiles associated with chronic allograft nephropathy

METHODS AND AGENTS FOR TREATING, PREVENTING, DIAGNOSING, AND EVALUATING THERAPY FOR FIBROTIC, AUTOIMMUNE, AND INFLAMMATORY CONDITIONS

CORONAVIRUS REPLICONS FOR ANTIVIRAL SCREENING AND TESTING

Methods for sequencing samples

GENETIC ALTERATIONS ASSOCIATED WITH EOSINOPHILIC ESOPHAGITIS AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF DISEASE

TREATMENT OF ALZHEIMER'S DISEASE

Method for Identifying Microorganisms and/or Their Resistance to Drugs, Cartridge and Related Cartridge Panel to Perform the Method

METHOD FOR PREDICTING AND EVALUATING ANTIMICROBIAL THERAPY WHEN MOLECULAR PCR DIAGNOSTIC TESTING RESULTS YIELD MULTI-ORGANISMS AND MULTI-RESISTANT BACTERIA FROM A SINGLE DNA SAMPLE

PHARMACEUTICAL COMPOSITION FOR ANTI-CANCER COMPRISING NUPR1 ISOFORM A INHIBITOR

METHODS AND COMPOSITIONS FOR RISK PREDICTION, DIAGNOSIS, PROGNOSIS, AND TREATMENT OF PULMONARY DISORDERS

Association of genetic variations to diagnose and treat attention-deficit hyperactivity disorder (ADHD)

METHOD FOR DIAGNOSIS AND/OR PROGNOSIS OF LIVER DISEASE PROGRESSION AND RISK OF HEPATOCELLULAR CARCINOMA AND DISCOVERY OF THERAPEUTIC COMPOUNDS AND TARGETS TO TREAT LIVER DISEASE AND CANCER

USING FLUORESCENT COLLAGEN .alpha. 1(I) AND .alpha. 2(I) mRNAs TO SCREEN DRUG CANDIDATES

GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

COMPOSITION FOR DIAGNOSING OR TREATING KIDNEY DISEASE

IN VITRO NEPHROTOXICITY SCREENING ASSAY

DUAL PROMOTER-DRIVEN AND DUAL REPORTER-EXPRESSING SARS-COV-2 REPLICONS AND METHODS OF USE

SMARCA4 INHIBITION FOR THE TREATMENT OF CANCER

METHOD FOR SCREENING FOR BIOACTIVE NATURAL PRODUCTS

METHOD FOR SCREENING COLORECTAL CANCER METASTASIS INHIBITOR

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS

IDENTIFICATION OF GENOME REGIONS ASSOCIATED WITH KIDNEY DISEASE AND TREATMENT

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

KIF5B-RET fusion molecules and uses thereof

Methods for Modulating Bile Acid Homeostasis and Treatment of Bile Acid Disorders and Diseases

METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS

DETECTION METHOD USING EUKARYOTIC CELLS

Biomarkers Related to Oral Squamous Cell Carcinoma and Methods of Diagnosis and Treatment Thereof

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

DETECTING A CHROMOSOME CONFIRMATION AS MARKER FOR FIBROSIS, E.G. SLERODERMA

GENE AND MUTATIONS THEREOF ASSOCIATED WITH SEIZURE AND MOVEMENT DISORDERS

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

METHODS OF IDENTIFYING MODULATORS OF THE IL-17 PATHWAY

METHOD OF SCREENING A THERAPY FOR INDUCTION OF FERROPTOSIS

ASSAY FOR DRUG DISCOVERY BASED ON IN VITRO DIFFERENTIATED CELLS

MARKER COMPOSITION FOR CANCER DIAGNOSIS OR PROGNOSIS BASED ON EXOSOME OVEREXRESSING GCC2

LONG NON-CODING RNA LETN SERVING AS TUMOR MARKER AND THERAPEUTIC TARGET POINT

NUCLEIC ACID CONSTRUCT, AND THERAPEUTIC OR DIAGNOSTIC AGENT FOR MISMATCH REPAIR DEFICIENT CANCERS COMPRISING NUCLEIC ACID CONSTRUCT

BACTERIAL DELIVERY VEHICLES COMPRISING TRACER NUCLEIC ACID SEQUENCES

GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISEASES, METHODS OF DETECTION AND USES THEREOF

REGULATORY ELEMENTS IN THE GENOME

Personalized immunotherapy against several neuronal and brain tumors

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Regulating Activation of Fibroblasts to Prevent Fibrosis

METHODS AND COMPOSITION FOR THE PREDICTION OF THE ACTIVITY OF ENZASTAURIN

METHODS FOR TREATING CANCER AND THE USE OF BIOMARKERS AS A PREDICTOR OF CLINICAL SENSITIVITY TO THERAPIES

METHOD OF DETERMINING SKIN AGING

Methods for diagnosing, prognosing, and treating parkinson's disease or parkinsonism

GENETIC, DEVELOPMENTAL AND MICRO-ENVIRONMENTAL PROGRAMS IN IDH-MUTANT GLIOMAS, COMPOSITIONS OF MATTER AND METHODS OF USE THEREOF

miRNA AS BIOMARKER FOR PARKINSON'S DISEASE AND DIAGNOSTIC KIT USING SAME

METHODS, COMPOSITIONS, KITS AND USES THEREOF TARGETING AND/OR TREATING VRK2 TO ENHANCE EFFECTIVENESS OF IMMUNE CHECKPOINT INHIBITOR(S)

Compositions and methods for rapid identification and phenotypic antimicrobial susceptibility testing of bacteria and fungi

Personalized immunotherapy against several neuronal and brain tumors

Personalized immunotherapy against several neuronal and brain tumors

METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS

Markers of acute myeloid leukemia stem cells

P53-destabilizing protein associated with proto-oncogene stemness as a therapeutic target and inhibitors thereof for use in treatment of cancer

In vitro or ex vivo methods for screening a quinoline derivative

SAMPLE DNA PREPARATION USING NUCLEASE

High performance multi-input microRNA sensors and uses thereof

METHODS FOR INHIBITING MUSCLE ATROPHY

TUMOUR MARKER AND USE THEREOF

Markers of acute myeloid leukemia stem cells

COMPOSITIONS AND METHODS FOR DETERMINING THE PROGNOSIS OF BLADDER UROTHELIAL CANCER

LEUKAEMIC STEM CELLS

BIOMARKER FOR DIAGNOSIS OF CEREBRAL NERVOUS SYSTEM DISEASES

METASTASIS SPECIFIC SPLICE VARIANTS OF MENA AND USES THEREOF IN DIAGNOSIS, PROGNOSIS AND TREATMENT OF TUMORS

MODULATORS OF TELOMERE DISEASE

Method of treating aging-associated cognitive impairment by reducing CCR3

MODULATION OF TRANSTHYRETIN EXPRESSION

METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY

Molecular Signatures for Distinguishing Liver Transplant Rejections or Injuries

BCR-ABL variants

INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AS A BIOMARKER AND USES THEREOF

IDENTIFICATION OF DRUGS TARGETING NON-GENETIC DRUG TOLERANCE PROGRAMS IN CANCER

Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereof

METHODS AND SYSTEMS FOR IDENTIFYING MODULATORS OF PERVASIVE DEVELOPMENTAL DISORDERS

NOVEL USE OF REGULATORY T CELL-SPECIFIC SURFACE PROTEIN LRIG-1

PROGNOSTIC MARKERS IN LUNG CANCER, PROGNOSTIC TYPING MODEL OF LUNG CANCER, AND APPLICATION THEREOF

Polycomb-associated Non-Coding RNAs

METHOD OF TREATING OR PREVENTING NEURODEGENERATION

COMPOSITIONS AND METHODS COMPRISING HISTIDYL-TRNA SYNTHETASE SPLICE VARIANTS HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES

IDENTIFICATION OF MOLECULAR PATHWAYS AND METHODS OF USE THEREOF FOR TREATING RETINAL NEURODEGENERATION AND OTHER NEURODEGENERATIVE DISORDERS

Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10)

SCREENING METHOD FOR SELECTED AMINO-LIPID-CONTAINING COMPOSITIONS

Editing profiling of PDE8A pre-mRNA: use as specific biomarker of ADARs activities in human tissues to diagnose and to predict and assess therapeutic efficacy and/or efficiency or potential drug side effects

Application of ERH gene in the preparation of bladder cancer diagnosis and treatment products

IDENTIFICATION OF PEDIATRIC ONSET INFLAMMATORY BOWEL DISEASE LOCI AND METHODS FOR USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

USE OF SHROOM3 IN CHRONIC KIDNEY DISEASE AND CHRONIC ALLOGRAFT NEPHROPATHY

Antisense nucleic acids

PHARMACEUTICAL COMPOSITION THAT INHIBITS PRODUCTION OF HEPATITIS B VIRUS PROTEIN AND SCREENING METHOD

CHEMOTHERAPEUTIC REMODELING OF THE GUT MICROBIOME

METHOD FOR FORECASTING ARRIVAL OF DRUG INSIDE DISEASED TISSUE

Markers of acute myeloid leukemia stem cells

Methods of Selecting T Cell Line and Donor Thereof for Adoptive Cellular Therapy

INFLAMMATION-ENABLING POLYPEPTIDES AND USES THEREOF

METHODS OF IDENTIFYING DRUG-MODULATED POLYPEPTIDE TARGETS FOR DEGRADATION

METHODS FOR IDENTIFYING THERAPEUTIC TARGETS AND TREATING AND MONITORING CANCERS

METHOD FOR DETECTING GENOME-RELATED INFORMATION OF CELL COEXISTING WITH AT LEAST ONE TYPE OF TEST SUBSTANCE

METHODS FOR DETERMINING DRUG EFFICACY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, MULTIPLE MYELOMA, AND MYELOID CANCERS

Inhibitors of alpha-tubulin acetylation for the treatment of pain

Personalized immunotherapy against several neuronal and brain tumors

FUS/TLS-BASED COMPOUNDS AND METHODS FOR DIAGNOSIS, TREATMENT AND PREVENTION OF AMYOTROPHIC LATERAL SCLEROSIS AND RELATED MOTOR NEURON DISEASES

Methods of Manipulating the Fate of Cells

CANCER SPECIFIC IMMUNOTHERAPEUTIC TARGETS GENERATED BY CHEMOTHERAPEUTIC DRUG TREATMENT

Personalized immunotherapy against several neuronal and brain tumors

CXCL13 Marker For Predicting Immunotherapeutic Responsiveness In Patient With Lung Cancer And Use Thereof

GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISORDERS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF

Use of regulatory T cell-specific surface protein LRIG-1

DIAGNOSTIC AND THERAPEUTIC METHODS FOR CANCER

METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS

Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof

METHODS FOR DISEASE TREATMENT AND DRUG DISCOVERY

GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA

Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof

Hepatitis A Virus Replication Inhibitor Targeting mTOR

Method for screening for skin whitening agent by using SDF1 promoter region

Uterine cancer treatments

TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS

Uterine cancer treatments

PRECISION DRUG SCREENING FOR PERSONALIZED CANCER THERAPY

Methods of treating and prognosing nonhematopoietic malignant tumors

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

METHOD FOR DETERMINING DECREASE IN FUNCTIONS OF HIPPOCAMPUS BY USING CORRELATION BETWEEN MICRO RNA AND NMDA RECEPTOR, METHOD FOR INHIBITING DECREASE IN FUNCTIONS, AND METHOD FOR SCREENING FOR INHIBITORS OF DECREASE IN FUNCTIONS

ASSOCIATION OF RARE RECURRENT GENETIC VARIATIONS TO ATTENTION-DEFICIT, HYPERACTIVITY DISORDER (ADHD) AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

ISOLATED BACTERIAL STRAIN FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T-CELLS

Methods for manipulating phagocytosis mediated by CD47

Personalized immunotherapy against several neuronal and brain tumors

Treatment and diagnosis of melanoma

TREATMENT METHODS

Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders

Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders

METHOD FOR SCREENING AGENTS PROMOTING SKIN BARRIER FUNCTION AND METHOD FOR EVALUATING SKIN BARRIER FUNCTION TAKING EPIDERMAL SERINE RACEMASE AND/OR D-SERINE LEVEL AS INDICATOR

Methods of in vivo evaluation of gene function

PHARMACEUTICAL USE OF ACTININ-4 INVOLVED IN INDUCTION OF CERVICAL CANCER

Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof

Compositions and methods for immune repertoire sequencing

METHOD OF IN SITU GENE SEQUENCING

Modulation of gene expression and screening for deregulated protein expression

Compositions and methods for rapid identification and phenotypic antimicrobial susceptibility testing of bacteria and fungi

Treatment of angiogenesis disorders

COMPOSITIONS AND METHODS FOR ENHANCING ODORANT RECEPTOR ACTIVITY

Compounds and matrices for use in bone growth and repair

Methods and systems of processing complex data sets using artificial intelligence and deconvolution

Targeting chromosomal instability and downstream cytosolic DNA signaling for cancer treatment

NOVEL KINASE FOR TREATING AND PREVENTING FUNGAL INFECTIONS, AND USE THEREOF

Production of fertile XY female animals by silencing of genes on the Y chromosome

Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants

TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS

DIGITALIZED HUMAN ORGANOIDS AND METHODS OF USING SAME

Exosomal microRNA in serum as an indicator for the activation of brown and beige fat tissue (BAT)

METHODS OF MODULATING NKX6.3

Target Gene Identifying Method for Tumor Treatment

Means and methods to treat inflammatory diseases

Use of quinoline derivatives for the treatment of inflammatory diseases

Methods of treating or preventing fibrosis in non-alcoholic fatty liver disease

Method of treating or preventing neurodegeneration

Translocation and mutant ROS kinase in human non-small cell lung carcinoma

METHOD OF TREATING OR PREVENTING NEURODEGENERATION

Use of quinoline derivatives for the treatment of inflammatory diseases

COMPOSITIONS AND METHODS FOR THERAPEUTICS PRESCREENING

Markers of acute myeloid leukemia stem cells

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES

Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments

TREATMENTS TO ELIMINATE HIV RESERVOIRS AND REDUCE VIRAL LOAD

Methods of Novel Therapeutic Candidate Identification Through Gene Expression Analysis in Vascular-Related Diseases

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

MEK1 mutation conferring resistance to RAF and MEK inhibitors

METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCES

Bacterial delivery vehicles comprising tracer nucleic acid sequences

TISSUE MOLECULAR SIGNATURES OF KIDNEY TRANSPLANT REJECTIONS

METHODS AND MATERIALS FOR ASSESSING LOSS OF HETEROZYGOSITY

Gene expression profiles associated with chronic allograft nephropathy

Method of reducing the effects of aging-associated impairment of neurogenesis comprising modulating c-c chemokine receptor type 3 (CCR3)

CANCER THERAPEUTIC TARGETING USING MUTANT P53-SPECIFIC SIRNAS

METHODS OF MODULATING ALK